Article

You have full text access to this OnlineOpen article

L2′ loop is critical for caspase-7 active site formation

  1. Witold A. Witkowski,
  2. Jeanne A. Hardy*

Article first published online: 29 APR 2009

DOI: 10.1002/pro.151

Issue

Protein Science

Protein Science

Volume 18, Issue 7, pages 1459–1468, July 2009

Additional Information

How to Cite

Witkowski, W. A. and Hardy, J. A. (2009), L2′ loop is critical for caspase-7 active site formation. Protein Science, 18: 1459–1468. doi: 10.1002/pro.151

Author Information

  1. Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01003

*Department of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003

Publication History

  1. Issue published online: 23 JUN 2009
  2. Article first published online: 29 APR 2009
  3. Accepted manuscript online: 29 APR 2009 12:00AM EST
  4. Manuscript Accepted: 13 APR 2009
  5. Manuscript Revised: 6 APR 2009
  6. Manuscript Received: 6 FEB 2009

Funded by

  • NIH. Grant Number: GM080532
  • The Medical Foundation
  • The Arnold and Mabel Beckman Foundation (Young Investigator Award)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (668K)

References

  • 1
    Reed JC, Tomaselli KJ ( 2000) Drug discovery opportunities from apoptosis research. Curr Opin Biotechnol 11: 586–592.
  • 2
    Rawlings ND, Barrett AJ ( 1993) Evolutionary families of peptidases. Biochem J 290: 205–218.
  • 3
    Srinivasula SM, Ahmad M, MacFarlane M, Luo Z, Huang Z, Fernandes-Alnemri T, Alnemri ES ( 1998) Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J Biol Chem 273: 10107–10111.
  • 4
    Denault JB, Salvesen GS ( 2003) Human caspase-7 activity and regulation by its N-terminal peptide. J Biol Chem 278: 34042–34050.
  • 5
    Denault JB, Salvesen GS ( 2008) Apoptotic caspase activation and activity. Methods Mol Biol 414: 191–220.
  • 6
    Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ ( 1994) Structure and mechanism of interleukin-1 β converting enzyme. Nature 370: 270–275.
  • 7
    DeLano WL ( 2002) The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific. Available at: http://www.pymol.org.
  • 8
    Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y ( 2001) Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell 107: 399–407.
  • 9
    Ridel SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salveson GS, Bode W ( 2001) Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA 98: 14790–14795.
  • 10
    Wei Y, Fox T, Chambers SP, Sintchak J, Coll JT, Golec JM, Swenson L, Wilson KP, Charifson PS ( 2000) The structures of caspases-1, -3, -7, and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol 7: 423–432.
  • 11
    Chai J, Shiozaki E, Srinivasula SM, Wu Q, Datta P, Alnemri ES, Shi Y ( 2001) Structural basis of caspase-7 inhibition by XIAP. Cell 104: 769–780.
  • 12
    Agniswamy J, Fang B, Weber IT ( 2007) Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis. FEBS J 274: 4752–4765.
  • 13
    Hardy JA, Lam J, Nguyen JT, O'Brien T, Wells JA ( 2004) Discovery of an allosteric site in the caspases. Proc Natl Acad Sci USA 101: 12461–12466.
  • 14
    Berger AB, Witte MD, Denault JB, Sadaghiani AM, Sexton KM, Salvesen GS, Bogyo M ( 2006) Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol Cell 23: 509–521.
  • 15
    Denault JB, Bekes M, Scott FL, Sexton KM, Bogyo M, Salvesen GS ( 2006) Engineered hybrid dimers: tracking the activation pathway of caspase-7. Mol Cell 23: 523–533.
  • 16
    Datta D, Scheer JM, Romanowski MJ, Wells JA ( 2008) An allosteric circuit in caspase-1. J Mol Biol 381: 1157–1167.
  • 17
    Roy S, Bayly CI, Gareau Y, Houtzager VM, Kargman S, Keen SL, Rowland K, Seiden IM, Thornberry NA, Nicholson DW ( 2001) Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide. Proc Natl Acad Sci USA 98: 6132–6137.
  • 18
    Feeney B, Pop C, Swartz P, Mattos C, Clark AC ( 2006) Role of loop bundle hydrogen bonds in the maturation and activity of (Pro)caspase-3. Biochemistry 45: 13249–13263.
  • 19
    Mittl PR, Di Marco S, Krebs JF, Bai X, Karanewsky DS, Priestle JP, Tomaselli KJ, Grutter MG ( 1997) Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J Biol Chem 272: 6539–6547.
  • 20
    Choong IC, Lew W, Lee D, Pham P, Burdett MT, Lam JW, Wiesmann C, Luong TN, Fahr B, DeLano WL, McDowell RS, Allen DA, Erlanson DA, Gordon EM, O'Brien T ( 2002) Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design. J Med Chem 45: 5005–5022.
  • 21
    Ni C, Li C, Wu J, Spada A, Ely K ( 2003) Conformational restrictions in the active site of unliganded human caspase-3. J Mol Recognit 16: 121–124.
  • 22
    Ganesan R, Mittl PR, Jelakovic S, Grutter MG ( 2006) Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis. J Mol Biol 359: 1378–1388.
  • 23
    Fu G, Chumanevich AA, Agniswamy J, Fang B, Harrison RW, Weber IT ( 2008) Structural basis for executioner caspase recognition of P5 position in substrates. Apoptosis 13: 1291–1302.
  • 24
    Xu J, Baase WA, Baldwin E, Matthews BW ( 1998) The response of T4 lysozyme to large-to-small substitutions within the core and its relation to the hydrophobic effect. Protein Sci 7: 158–177.
  • 25
    Jackson MR, Laurie TRA, University of Leeds ( 2004) http://www.modelling.leeds.ac.uk/pocketfinder/ Pocket-Finder Pocket Detection.
  • 26
    Gassner NC, Baase WA, Matthews BW ( 1996) A test of the “jigsaw puzzle” model for protein folding by multiple methionine substitutions within the core of T4 lysozyme. Proc Natl Acad Sci USA 93: 12155–12158.
  • 27
    Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM, Alnemri ES, Fairman R, Shi Y ( 2003) Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 11: 519–527.
  • 28
    Renatus M, Stennicke HR, Scott FL, Liddington RC, Salvesen GS ( 2001) Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci USA 98: 14250–14255.
  • 29
    Piana S, Sulpizi M, Rothlisberger U ( 2003) Structure-based thermodynamic analysis of caspases reveals key residues for dimerization and activity. Biochemistry 42: 8720–8728.
  • 30
    Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salvesen GS, Bode W ( 2001) Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA 98: 14790–14795.
  • 31
    Batchelor AH, Piper DE, de la Brousse FC, McKnight SL, Wolberger C ( 1998) The structure of GABPα/β: an ETS domain-ankyrin repeat heterodimer bound to DNA. Science 279: 1037–1041.
  • 32
    Otwinowski Z, Minor W ( 1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307–326.
  • 33
    Dodson E, Winn M, Ralph A ( 1997) Collaborative computational Project, number 4: providing programs for protein crystallography. Methods Enzymol 277: 620–633.
  • 34
    Jones T, Zou J, Cowan S, Kjeldgaard M ( 1991) Improved methods for the building of protein models in electron density maps and the locations of errors in these models. Acta Crystallogr A 47: 110–119.
View Full Article with Supporting Information (HTML) Get PDF (668K)